![]()
|
|
||||||||
J Biol Chem, Vol. 275, Issue 4, 2520-2526, January 28, 2000
From the Departments of Activation of the antitubercular isoniazid (INH)
by the Mycobacterium tuberculosis KatG produces an
inhibitor for enoyl reductase (InhA). The mechanism for INH activation
remains poorly understood, and the inhibitor has never been isolated.
We have purified the InhA-inhibitor complex generated in the M. tuberculosis KatG-catalyzed INH activation. The complex exhibited
a 278-nm absorption peak and a shoulder around 326 nm with a
characteristic
A326/A278 ratio of
0.16. The complex was devoid of enoyl reductase activity. The inhibitor
noncovalently binds to InhA with a Kd < 0.4 nM and can be dissociated from denatured InhA for
chromatographic isolation. The free inhibitor showed absorption peaks
at 326 (
Action Mechanism of Antitubercular Isoniazid
ACTIVATION BY MYCOBACTERIUM TUBERCULOSIS KatG,
ISOLATION, AND CHARACTERIZATION OF InhA INHIBITOR*
,
, and
§¶
Biology and Biochemistry and
§ Chemistry, University of Houston,
Houston, Texas 77204-5513
326 6900 M
1
cm
1) and 260 nm (
260 27,000 M
1 cm
1). The inactive complex
can be reconstituted from InhA and the isolated inhibitor. The InhA
inhibitor from the KatG-catalyzed INH activation was identical to that
from a slow, KatG-independent, Mn2+-mediated reaction based
on high pressure liquid chromatography analysis and absorption and mass
spectral characteristics. By monitoring the formation of the
InhA-inhibitor complex, we have found that manganese is not essential
to the INH activation by M. tuberculosis KatG. Furthermore,
the formation of the InhA inhibitor in the KatG reaction was
independent of InhA.
*
This work was supported by Grant GM25953 from the National
Institutes of Health and Grant E-1030 from The Robert A. Welch Foundation.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
This article has been cited by other articles:
![]() |
F. Wang, R. Langley, G. Gulten, L. G. Dover, G. S. Besra, W. R. Jacobs Jr., and J. C. Sacchettini Mechanism of thioamide drug action against tuberculosis and leprosy J. Exp. Med., January 22, 2007; 204(1): 73 - 78. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Brossier, N. Veziris, C. Truffot-Pernot, V. Jarlier, and W. Sougakoff Performance of the Genotype MTBDR Line Probe Assay for Detection of Resistance to Rifampin and Isoniazid in Strains of Mycobacterium tuberculosis with Low- and High-Level Resistance. J. Clin. Microbiol., October 1, 2006; 44(10): 3659 - 3664. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Ghiladi, G. M. Knudsen, K. F. Medzihradszky, and P. R. O. de Montellano The Met-Tyr-Trp Cross-link in Mycobacterium tuberculosis Catalase-peroxidase (KatG): AUTOCATALYTIC FORMATION AND EFFECT ON ENZYME CATALYSIS AND SPECTROSCOPIC PROPERTIES J. Biol. Chem., June 17, 2005; 280(24): 22651 - 22663. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Singh, B. Wiseman, T. Deemagarn, L. J. Donald, H. W. Duckworth, X. Carpena, I. Fita, and P. C. Loewen Catalase-peroxidases (KatG) Exhibit NADH Oxidase Activity J. Biol. Chem., October 8, 2004; 279(41): 43098 - 43106. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Pierattelli, L. Banci, N. A. J. Eady, J. Bodiguel, J. N. Jones, P. C. E. Moody, E. L. Raven, B. Jamart-Gregoire, and K. A. Brown Enzyme-catalyzed Mechanism of Isoniazid Activation in Class I and Class III Peroxidases J. Biol. Chem., September 10, 2004; 279(37): 39000 - 39009. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ducasse-Cabanot, M. Cohen-Gonsaud, H. Marrakchi, M. Nguyen, D. Zerbib, J. Bernadou, M. Daffe, G. Labesse, and A. Quemard In Vitro Inhibition of the Mycobacterium tuberculosis {beta}-Ketoacyl-Acyl Carrier Protein Reductase MabA by Isoniazid Antimicrob. Agents Chemother., January 1, 2004; 48(1): 242 - 249. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Rawat, A. Whitty, and P. J. Tonge The isoniazid-NAD adduct is a slow, tight-binding inhibitor of InhA, the Mycobacterium tuberculosis enoyl reductase: Adduct affinity and drug resistance PNAS, November 25, 2003; 100(24): 13881 - 13886. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Kremer, L. G. Dover, H. R. Morbidoni, C. Vilcheze, W. N. Maughan, A. Baulard, S.-C. Tu, N. Honore, V. Deretic, J. C. Sacchettini, et al. Inhibition of InhA Activity, but Not KasA Activity, Induces Formation of a KasA-containing Complex in Mycobacteria J. Biol. Chem., May 30, 2003; 278(23): 20547 - 20554. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-J. Wei, B. Lei, J. M. Musser, and S.-C. Tu Isoniazid Activation Defects in Recombinant Mycobacterium tuberculosis Catalase-Peroxidase (KatG) Mutants Evident in InhA Inhibitor Production Antimicrob. Agents Chemother., February 1, 2003; 47(2): 670 - 675. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Chouchane, S. Girotto, S. Yu, and R. S. Magliozzo Identification and Characterization of Tyrosyl Radical Formation in Mycobacterium tuberculosis Catalase-Peroxidase (KatG) J. Biol. Chem., November 1, 2002; 277(45): 42633 - 42638. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Lei, L. M. Smoot, H. M. Menning, J. M. Voyich, S. V. Kala, F. R. Deleo, S. D. Reid, and J. M. Musser Identification and Characterization of a Novel Heme-Associated Cell Surface Protein Made by Streptococcus pyogenes Infect. Immun., August 1, 2002; 70(8): 4494 - 4500. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nguyen, A. Quemard, S. Broussy, J. Bernadou, and B. Meunier Mn(III) Pyrophosphate as an Efficient Tool for Studying the Mode of Action of Isoniazid on the InhA Protein of Mycobacterium tuberculosis Antimicrob. Agents Chemother., July 1, 2002; 46(7): 2137 - 2144. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Vilchèze, H. R. Morbidoni, T. R. Weisbrod, H. Iwamoto, M. Kuo, J. C. Sacchettini, and W. R. Jacobs Jr. Inactivation of the inhA-Encoded Fatty Acid Synthase II (FASII) Enoyl-Acyl Carrier Protein Reductase Induces Accumulation of the FASI End Products and Cell Lysis of Mycobacterium smegmatis J. Bacteriol., July 15, 2000; 182(14): 4059 - 4067. [Abstract] [Full Text] |
||||
![]() |
A. R. Baulard, J. C. Betts, J. Engohang-Ndong, S. Quan, R. A. McAdam, P. J. Brennan, C. Locht, and G. S. Besra Activation of the Pro-drug Ethionamide Is Regulated in Mycobacteria J. Biol. Chem., September 1, 2000; 275(36): 28326 - 28331. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |